Just another Daily Blogs News weblog
|
Teva Moves Ahead in Brain Drug Battle
Forbes Inc.'s Temodar is unenforceable, allowing Teva Pharmaceuticals USA Inc. to sell a generic version of the chemotherapy drug. Israel-based Teva, the world's … Court rules for Teva in Merck cancer drug suitBusinessWeek Teva wins court battle with MerckPhiladelphia Inquirer US Judge Rules Against Merck In Cancer-Drug Patent DisputeCNNMoney.com Behavioral Health Central (blog) -Drug Store News (blog) -Reuters all 50 news articles » |
Teva Moves Ahead in Brain Drug Battle – Forbes

Related posts:

Get News Headline on the motion